Clinical stage of SCC n (%) | |||||
---|---|---|---|---|---|
IA/IB n = 8 | IIA/IIB n = 21 | IIIA/IIIB n = 23 | IVA/IVB n = 15 | N/A n = 38 | |
All genotypes | 7 (87.5%) | 17 (80.9%) | 20 (86.9%) | 14 (93.3%) | 34 (89.5%) |
HPV16 | 2 | 10 | 15 | 8 | 20 |
HPV18 | – | – | 3 | – | 2 |
HPV33 | 1 | – | – | – | 3 |
HPV45 | – | 2 | – | 1 | – |
HPV58 | – | 2 | – | – | 2 |
HPV59 | – | – | – | – | 1 |
HPV16, 18 | 2 | 2 | – | 2 | 4 |
HPV16, 45 | 1 | – | 1 | – | – |
HPV16, 58 | 1 | – | 1 | 2 | 2 |
HPV18, 58 | – | – | – | 1 | – |
HPV16, 18, 45 | – | 1 | – | – | – |